Longer Patents for Increased Generic Competition : The Waxman-Hatch Act after One Decade

The 1984 Drug Price Competition and Patent Term Restoration Act (the Waxman-Hatch Act) is unique in many ways. This Law was the first change in U.S. patent terms since 1861. It simultaneously lowered the barrier to entry for generic drug firms and increased patent terms for new drugs delayed by FDA regulation. In this paper, we analyze the Act has performed in practice, determining whether the Law has resulted in cheaper and better drugs

MoreLess

Year of publication:	2013
Authors:	Grabowski, Henry G. ; Vernon, John M.
Publisher:	[S.l.] : SSRN
Subject:	Patent \| Generika \| Generic drugs \| Wettbewerb \| Competition \| Patentrecht \| Patent law

freely available

Full text |

More access options

doi.org

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (34 p)
Type of publication:	Book / Working Paper
Language:	English
Other identifiers:	10.2139/ssrn.40940 [DOI]
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10014084787